Clinical and scientific impact of National Cancer Institute: Sponsored clinical trial network group treatment trials

被引：0

作者：

Unger, J. M. ^{[1
]}

LeBlanc, M. ^{[1
]}

Bertagnolli, M. ^{[2
]}

Wolmark, N. ^{[3
]}

Curran, W. J. ^{[4
]}

O'Dwyer, P. J. ^{[5
]}

Schnall, M. D. ^{[6
]}

Mannel, R. S. ^{[7
]}

Costantino, J. P. ^{[8
]}

Gray, R. J. ^{[9
]}

Zhao, F. ^{[9
]}

Hong, F. ^{[10
]}

Bah, M. ^{[11
]}

Vaidya, R. ^{[11
]}

Blanke, C. D. ^{[12
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA

[2] Brigham & Womens Hosp, Surg Oncol, 75 Francis St, Boston, MA 02115 USA

[3] Allegheny Gen Hosp, Allegheny Canc Ctr, Pittsburgh, PA 15212 USA

[4] Emory Univ, Winship Canc Inst, Med Dept, Atlanta, GA 30322 USA

[5] Univ Penn, Med Oncol, Franklin Bldg, Philadelphia, PA 19104 USA

[6] Verwoerd Hosp, Med Oncol, Pretoria, South Africa

[7] Stephenson Canc Ctr, Med Oncol, Oklahoma City, OK USA

[8] Univ Pittsburgh, Biostat, Pittsburgh, PA USA

[9] Dana Farber Canc Inst, Biostat, Boston, MA 02115 USA

[10] Harvard Univ, Biostat, Boston, MA 02115 USA

[11] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA

[12] SWOG Canc Res Network, Med Dept, Portland, OR USA

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.annonc.2021.08.832

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1503O

引用

页码：S1102 / S1103

页数：2

共 50 条

[21] THE NATIONAL IMPACT OF CLINICAL COOPERATIVE GROUP TRIALS FOR PEDIATRIC CANCER
MURPHY, SB
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (05): : 279 - 280
[22] Trends in disparities in clinical trial accrual: An analysis of National Cancer Institute (NCI)-sponsored early phase clinical trials over the last 22 years
Farooq, Maria
Sharon, Elad
Takebe, Naoko
Best, Ana F.
Finnigan, Shanda
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
[23] Factors affecting workload of cancer clinical trials: Results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group
Roche, K
Paul, N
Smuck, B
Whitehead, M
Zee, B
Pater, J
Hiatt, MA
Walker, H
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 545 - 556
[24] Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the national cancer institute-sponsored clinical trials networks
Bruner, Deborah Watkins
Bryan, Charlene J.
Aaronson, Neil
Blackmore, C. Craig
Brundage, Michael
Cella, David
Ganz, Patricia A.
Gotay, Carolyn
Hinds, Pamela S.
Kornblith, Alice B.
Movsas, Benjamin
Sloan, Jeff
Wenzel, Lari
Whalen, Giles
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5051 - 5057
[25] TESTING HYPOTHESES IN CLINICAL-TRIALS - EXPERIENCE OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
PATER, JL
EISENHAUER, E
SHELLEY, W
WILLAN, AR
CANCER TREATMENT REPORTS, 1986, 70 (09): : 1133 - 1136
[26] Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute
Smith, MA
Ungerleider, RS
Korn, EL
Rubinstein, L
Simon, R
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) : 2736 - 2743
[27] Bridging the Major Prospective National Eye Institute-sponsored Glaucoma Clinical Trials and Clinical Practice
De Moraes, Carlos Gustavo
Ritch, Robert
Liebmann, Jeffrey M.
JOURNAL OF GLAUCOMA, 2011, 20 (01) : 1 - 2
[28] Evaluating health-related quality of life in cancer clinical trials: The National Cancer Institute of Canada Clinical Trials Group experience
Osoba, David
Bezjak, Andrea
Brundage, Michael
Pater, Joseph
VALUE IN HEALTH, 2007, 10 : S138 - S145
[29] Perioperative Clinical Trials for Pancreatic Cancer in the National Clinical Trials Network
Matthew H. G. Katz
Annals of Surgical Oncology, 2019, 26 : 4173 - 4174
[30] Perioperative Clinical Trials for Pancreatic Cancer in the National Clinical Trials Network
Katz, Matthew H. G.
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4173 - 4174

← 1 2 3 4 5 →